Saturday, December 19, 2009

10th Tysabri went well yesterday.  Next Infusion Jan. 15, 2010.

1 comment:

Anonymous said...

What do you think of this?

"we were restricted by the Institutional Review Board to collect only data essential to the goal of our study"

"the goal of our studies was to test hematopoietic stem/progenitor cell (HSPC) mobilization in humans after a single dose ... with the anti–functional alpha4-integrin antibody natalizumab."